AU2002342188A8 - Methods and compositions for treating flavivirus-mediated disease - Google Patents
Methods and compositions for treating flavivirus-mediated diseaseInfo
- Publication number
- AU2002342188A8 AU2002342188A8 AU2002342188A AU2002342188A AU2002342188A8 AU 2002342188 A8 AU2002342188 A8 AU 2002342188A8 AU 2002342188 A AU2002342188 A AU 2002342188A AU 2002342188 A AU2002342188 A AU 2002342188A AU 2002342188 A8 AU2002342188 A8 AU 2002342188A8
- Authority
- AU
- Australia
- Prior art keywords
- compositions
- methods
- mediated disease
- treating flavivirus
- flavivirus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 241000710831 Flavivirus Species 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 230000001404 mediated effect Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US34073501P | 2001-10-30 | 2001-10-30 | |
US60/340,735 | 2001-10-30 | ||
PCT/US2002/034659 WO2003049672A2 (en) | 2001-10-30 | 2002-10-29 | Methods and compositions for treating flavivirus-mediated disease |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2002342188A8 true AU2002342188A8 (en) | 2003-06-23 |
AU2002342188A1 AU2002342188A1 (en) | 2003-06-23 |
Family
ID=23334710
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002342188A Abandoned AU2002342188A1 (en) | 2001-10-30 | 2002-10-29 | Methods and compositions for treating flavivirus-mediated disease |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2002342188A1 (en) |
WO (1) | WO2003049672A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008074720A (en) * | 2006-09-19 | 2008-04-03 | Noguchi Inst | Gm3 sugar chain probe |
CN102123706B (en) | 2008-06-17 | 2013-08-14 | 米纳斯吉拉斯联合大学 | Use of paf receptor for treating infections caused by flaviviridae |
CA3234210A1 (en) * | 2021-10-14 | 2023-04-20 | Max ALLSWORTH | Method for the synthesis of evoc probes |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE271560T1 (en) * | 1996-05-16 | 2004-08-15 | Nissin Food Products Ltd | COMPOUNDS WITH ANTIVIRAL ACTIVITY |
JP2002533400A (en) * | 1998-12-29 | 2002-10-08 | グルコール インコーポレーティッド | Treatment and prevention of HIV and other viral infections |
-
2002
- 2002-10-29 AU AU2002342188A patent/AU2002342188A1/en not_active Abandoned
- 2002-10-29 WO PCT/US2002/034659 patent/WO2003049672A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU2002342188A1 (en) | 2003-06-23 |
WO2003049672A2 (en) | 2003-06-19 |
WO2003049672A3 (en) | 2003-07-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1416961A4 (en) | Composition and method for the treatment of disease | |
IL160933A0 (en) | Methods and compositions for treating ?cap associated diseases | |
EP1446114A4 (en) | Compositions and methods for treating osteoporosis | |
HK1089364A1 (en) | Topical compositions and methods for treating pain | |
AU2002357119A8 (en) | Mitocidal compositions and methods | |
AP2006003708A0 (en) | Methods and compositions for treating flavivirusesand pestiviruses | |
IL208191A0 (en) | Compositions and methods for treating rage-associated disorders | |
AU6147401A (en) | Compositions and methods for the treatment of cancer | |
EP1545578A4 (en) | Compositions and methods for treating cardiovascular disease | |
GB0110288D0 (en) | Composition and treatment method | |
GB0601708D0 (en) | Compositions And Methods For Treating Gynaecological Disorders | |
EP1572118A4 (en) | Methods and compositions for treating cancer using 15986, 2188, 20743, 9148, 9151, 9791, 44252, 14184, 42461, 8204, 7970, 25552, 21657, 26492, 2411, 15088, 1905, 28899, 63380, 33935, 10480, 12686, 25501, 17694, 15701, 53062, 49908, 21612, 38949, 6216, 46863, 9235, 2201, 6985, 9883, 12238, 18057, 216 | |
EP1443820A4 (en) | Composition and method for treating graft-versus-host disease | |
HUP0400609A3 (en) | Wet-skin treatment compositions | |
AU2003212850A8 (en) | Methods and compositions for treating cardiovascular disease | |
EP1461047A4 (en) | Compositions and methods for animal treatment | |
AU2002367023A8 (en) | Compositions and methods for treating heart failure | |
AU2002365057A8 (en) | Compositions and methods for treating heart failure | |
AU2002357748A8 (en) | Osteopontin-related compositions and methods | |
GB0126643D0 (en) | Composition and process | |
PL368035A1 (en) | Compositions and methods for the treatment of cancer | |
EP1349548A4 (en) | Methods and compositions for treating periodontal disease | |
AU2003275433A8 (en) | Compositions and methods for treating pain | |
GB0130763D0 (en) | Treatment methods | |
EP1261331A4 (en) | Method and compositions for treating fibrotic diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |